Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.2130
-0.0006 (-0.28%)
At close: Jan 30, 2026, 4:00 PM EST
0.2102
-0.0028 (-1.31%)
After-hours: Jan 30, 2026, 7:05 PM EST
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $5.92 million as of January 30, 2026. Its market cap has decreased by -10.40% in one year.
Market Cap
5.92M
Enterprise Value
1.31M
1-Year Change
-10.40%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.34M to $5.92M, a decrease of -77.53%. That is a compound annual growth rate of -18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 5.92M | 0.92% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.56M | 131.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 6.60M |
| Purple Biotech | 6.58M |
| Silexion Therapeutics | 6.35M |
| Alaunos Therapeutics | 6.31M |
| Bio Green Med Solution | 6.20M |
| Acurx Pharmaceuticals | 6.06M |
| Abpro Holdings | 6.00M |
| Can-Fite BioPharma | 5.90M |